You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 9,226,903


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,226,903 protect, and when does it expire?

Patent 9,226,903 protects QUTENZA and is included in one NDA.

This patent has thirty-five patent family members in twenty-three countries.

Summary for Patent: 9,226,903
Title:Transdermal therapeutic system comprising an adhesive layer method for siliconizing the back layer or the system and use of said back layer
Abstract: The invention relates to a transdermal therapeutic system which comprises a backing layer, an adhesive layer, a polymer layer and a removable protective layer. The adhesive layer is an organosiloxane layer and is anchored in the backing layer by siliconization.
Inventor(s): Mueller; Walter (Andernach, DE), Leonhard; Johannes (Bendorf, DE)
Assignee: LTS Lohmann Therapie-Systeme AG (Andernach, DE)
Application Number:11/661,530
Patent Claim Types:
see list of patent claims
Use; Formulation;
Patent landscape, scope, and claims:

United States Patent 9,226,903: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 9,226,903, titled "Transdermal therapeutic system comprising an adhesive layer," is a significant patent in the field of pharmaceuticals and medical devices. This patent, granted to innovators in the healthcare sector, protects a specific transdermal therapeutic system designed to deliver medications through the skin. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Invention Description

The patent describes a transdermal therapeutic system that includes several key components: a backing layer, an adhesive layer, a polymer layer, and a removable protective layer. This system is designed to deliver therapeutic agents through the skin, providing a controlled and sustained release of the medication[5].

Scope of the Patent

Claims Analysis

The claims of a patent are its most critical part, as they define the scope of protection. For US Patent 9,226,903, the claims are structured to cover the specific components and their arrangement within the transdermal therapeutic system.

  • Independent Claims: These claims define the broadest scope of the invention. For example, Claim 1 might describe the overall system, including the backing layer, adhesive layer, polymer layer, and removable protective layer.
  • Dependent Claims: These claims narrow down the scope by adding specific details or limitations to the independent claims. For instance, a dependent claim might specify the type of adhesive used or the material composition of the polymer layer.

Scope Concepts

To understand the patent landscape, it is essential to categorize the patents by scope concepts. This involves grouping claims based on overarching concepts that link similar patents. For US Patent 9,226,903, scope concepts might include:

  • Transdermal Drug Delivery: This concept encompasses all claims related to the delivery mechanism of the therapeutic agents through the skin.
  • Adhesive Layer Composition: This concept includes claims that specify the materials and properties of the adhesive layer.
  • Polymer Layer Characteristics: This involves claims that describe the type, thickness, and other properties of the polymer layer[3].

Patent Claims and Coverage

Claim Coverage Matrix

A Claim Coverage Matrix is a tool used to determine which patents and claims are actively protecting the intellectual property. For US Patent 9,226,903, this matrix would help identify:

  • Active Claims: Which claims are currently protecting the transdermal therapeutic system.
  • Gaps in Coverage: Areas where the patent does not provide adequate protection, indicating potential vulnerabilities or opportunities for further innovation.
  • Future Design Opportunities: The matrix can highlight scope concepts that are valuable now or could be in the future, guiding R&D efforts[3].

Claim Charts

Claim charts generated by software like ClaimScape® can facilitate a quick and accurate review of patent coverage. These charts help technical experts, engineers, and management to determine if a particular scope concept is applicable to a target product or method. This tool is particularly useful for identifying gaps in current coverage and highlighting future design opportunities[3].

Patent Landscape

Competitor Patents

Analyzing the patent landscape involves identifying similar patents held by competitors. This can be done using tools like the USPTO's Global Dossier, which provides access to file histories of related applications from participating IP Offices. By examining these patents, one can identify:

  • Overlapping Claims: Claims that are similar or overlapping with those of US Patent 9,226,903.
  • Innovative Differences: Unique features or improvements in competitor patents that could be considered for future development[1].

Technology Trends

The patent landscape also reveals broader technology trends. For example, the field of transdermal drug delivery is constantly evolving, with new materials and delivery mechanisms being developed. By tracking these trends, innovators can stay ahead in the market and identify areas for further research and development.

Reissue and Continuation Procedures

Reissue Patents

If the original patent needs to be broadened or narrowed, the patent holder may seek a reissue patent. However, reissue claims must comply with the "original patent" requirement under 35 U.S.C. § 251, meaning they must be directed to the invention disclosed in the original patent. Any attempt to broaden the claims beyond what was originally disclosed can lead to invalidation of the reissue claims[2].

Continuation Applications

Continuation applications allow patent holders to further prosecute their inventions during the examination process. These can include continuation, divisional, and continuation-in-part applications. Understanding these procedures is crucial for maintaining and expanding the scope of protection for the transdermal therapeutic system[4].

Probability of Patent Allowance

The probability of receiving a patent, including continuations and reissues, can be complex. Studies have shown that the allowance rate varies based on factors such as the technology field, the origin of the application, and whether the applicant is a large or small entity. For instance, the family allowance rate, which includes the outcomes of continuation applications, provides a comprehensive view of the likelihood of obtaining at least one patent from a progenitor application[4].

Key Takeaways

  • Detailed Claims Analysis: Understanding the independent and dependent claims is crucial for defining the scope of protection.
  • Scope Concepts and Claim Coverage: Categorizing claims by scope concepts helps in identifying gaps and opportunities in the patent landscape.
  • Competitor Analysis: Examining competitor patents reveals overlapping claims and innovative differences.
  • Reissue and Continuation Procedures: Compliance with statutory requirements is essential for maintaining and expanding patent protection.
  • Technology Trends: Staying updated with industry trends is vital for continuous innovation and market dominance.

FAQs

Q: What is the main purpose of the transdermal therapeutic system described in US Patent 9,226,903?

A: The main purpose is to deliver therapeutic agents through the skin, providing a controlled and sustained release of medication.

Q: How can a Claim Coverage Matrix help in managing intellectual property?

A: A Claim Coverage Matrix helps identify which patents and claims are actively protecting the intellectual property, gaps in coverage, and future design opportunities.

Q: What is the significance of the "original patent" requirement in reissue patents?

A: The "original patent" requirement ensures that reissue claims must be directed to the invention disclosed in the original patent, preventing the broadening of claims beyond what was originally disclosed.

Q: How do continuation applications impact the patent landscape?

A: Continuation applications allow for further prosecution of the invention, enabling the patent holder to maintain and expand the scope of protection through various types of continuation procedures.

Q: What factors influence the probability of receiving a patent?

A: Factors such as the technology field, application origin, and whether the applicant is a large or small entity influence the probability of receiving a patent.

Sources

  1. USPTO: Search for patents - USPTO.
  2. Court of Appeals for the Federal Circuit: In Re FLOAT'N'GRILL LLC.
  3. Schwegman: Patent Analytics | Intellectual Property Law.
  4. Yale Journal of Law and Technology: What Is the Probability of Receiving a US Patent?
  5. PubChem: Transdermal therapeutic system comprising an adhesive layer ...

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,226,903

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Averitas QUTENZA capsaicin PATCH;TOPICAL 022395-001 Nov 16, 2009 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,226,903

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany10 2004 044 578Sep 13, 2004
PCT Information
PCT FiledSeptember 06, 2005PCT Application Number:PCT/EP2005/009547
PCT Publication Date:March 23, 2006PCT Publication Number: WO2006/029740

International Family Members for US Patent 9,226,903

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 050621 ⤷  Subscribe
Australia 2005284436 ⤷  Subscribe
Brazil PI0515270 ⤷  Subscribe
Canada 2578534 ⤷  Subscribe
China 101018545 ⤷  Subscribe
China 102755305 ⤷  Subscribe
Cyprus 1113997 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.